Ko-AutorschaftPeer Reviewed

Effects of Secukinumab on Cardio-metabolic Risk Proteomic profile in Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: The PROSEC Study

Autoren

González-Cantero Á, Barbarroja N, Llamas-Velasco M, de Aragón CAJ, Clemens A, et al.

Journal

Journal of the American Academy of Dermatology 95(1), AB178

Veröffentlichungsdatum

07/2026

Abstract

Effects of Secukinumab on Cardio-metabolic Risk Proteomic profile in Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: The PROSEC Study - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens